Precision Dealmaking

1:00 PM - 2:15 PM, Monday, June 8, 2020 ・ Room 6A
Just as precision medicine is the future of the industry, precision dealmaking has the potential to enhance innovation by meeting the needs of all stakeholders, including patients, innovators and investors. Recent deals have begun to demonstrate the value of precision dealmaking. What are the hallmarks of precision dealmaking? What creative structures have been deployed by successful partners? Throughout the negotiating process, how do dealmakers balance the goal of accelerating innovation for patients with the need to maximize the return on investment? Hear from a group of veteran dealmakers on how they approach the precision dealmaking process, their most notable successes and challenges, and what they’ve learned from their experiences.

Sponsored by Pfizer, Inc.
Chief Business Officer
Pfizer, Inc.